Health Care [ 10/12 ] | Health Care Providers & Services [ 48/74 ]
NASDAQ | Common Stock
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.
It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.
The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 1, 24 | -0.56 Increased by +9.68% | -0.52 Decreased by -7.69% |
| May 8, 24 | -0.55 Increased by +3.51% | -0.49 Decreased by -12.24% |
| Feb 29, 24 | -0.53 Increased by +27.40% | -0.33 Decreased by -60.61% |
| Nov 2, 23 | -0.67 Decreased by -55.81% | -0.43 Decreased by -55.81% |
| Aug 3, 23 | -0.62 Decreased by -24.00% | -0.69 Increased by +10.14% |
| May 11, 23 | -0.57 Decreased by -14.00% | -0.68 Increased by +16.18% |
| Feb 28, 23 | -0.73 Decreased by -19.67% | -0.59 Decreased by -23.73% |
| Nov 3, 22 | -0.43 Decreased by -13.16% | -0.65 Increased by +33.85% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | N/A Decreased by N/A% | -38.50 M Decreased by -15.31% | - - |
| Jun 30, 24 | 0.00 Decreased by N/A% | -38.10 M Decreased by -34.47% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -35.19 M Decreased by -45.35% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 3.68 M Increased by +N/A% | -32.81 M Decreased by -6.11% | Decreased by -891.05% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -33.39 M Decreased by -81.75% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -28.34 M Decreased by -34.69% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -24.21 M Decreased by -14.35% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -30.93 M Decreased by -20.57% | Decreased by N/A% Decreased by N/A% |